• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    Granules India Secures USFDA Tentative Approval For gDYANAVEL XR

    PRESS RELEASE

    Granules India Gets USFDA Tentative Approval For Amphetamine ER

    PRESS RELEASE

    Granules Strengthens ADHD Portfolio with FDA Approval

    PRESS RELEASE

    Granules India gets USFDA nod for ADHD Treatment

    PRESS RELEASE

    Granules India gets USFDA nod for generic Glycopyrrolate oral solution

    PRESS RELEASE

    Granules India Announced ANDA Approval for Colchicine Capsules

    PRESS RELEASE

    Granules India Generic gets USFDA nod for Pantoprazole Sodium

    PRESS RELEASE

    Granules India Received ANDA Approval for Sildenafil for Oral Suspension.

    PRESS RELEASE

    Granules Received ANDA Approval for Esomeprazole Magnesium Del-Release Capsules

    PRESS RELEASE

    Granules gets FDA nod for generic drug used for treatment of heartburn

    ECONOMIC TIMES

    Granules India Received ANDA Approval for Losartan and HCL Tablets

    PRESS RELEASE

    Granules Receives ANDA Approval for Levetiracetam Tablets in record 9 months

    PRESS RELEASE

    Granules India Received ANDA Approval for Metoprolol Succinate ER Tablets

    PRESS RELEASE

    Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules

    PRESS RELEASE

    Granules India receives USFDA approval for generic gabapentin tablets

    ECONOMIC TIMES

    Granules India Limited Received ANDA Approval for Losartan Potassium Tablets

    PRESS RELEASE

    Granules gets FDA nod to market generic medication to treat high blood pressure

    ECONOMIC TIMES

    Granules Pharma Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules

    PRESS RELEASE

    USFDA nod for Granules’ ANDA

    THEHINDU

    Granules charts aggressive growth story for next 3Y focusing on US generic biz

    MONEYCONTROL

    Granules receives US FDA approval for generic methylergonovine tablets

    PHARMABIZ

    Mitigare® (Colchicine): West-Ward Pharma Corp v. Granules Pharmaceuticals, Usa

    PATENT LITIGATION

    Granules to market Par Pharma`s generic heartburn drug in the US

    BUSINESS STANDARD

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.